The Difference in the Effects on Microalbuminuria Depending on the Order of GLP-1RA and SGLT2i Therapy in Type 2 Diabetes

被引：0
|
作者：
Ohara, Masaya
Motoyama, Koka
Tamai, Anna
Sakura, Takeshi
Yakushiji, Yosuke
Hosoi, Masayuki
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-545-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
545-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance
    Angelica Cersosimo
    Nadia Salerno
    Jolanda Sabatino
    Alessandra Scatteia
    Giandomenico Bisaccia
    Salvatore De Rosa
    Santo Dellegrottaglie
    Chiara Bucciarelli-Ducci
    Daniele Torella
    Isabella Leo
    Cardiovascular Diabetology, 23
  • [22] Sociodemographic disparities in GLP-1RA and SGLT2i use among US adults with type 2 diabetes: NHANES 2005-March 2020
    Mittman, Benjamin G.
    Le, Phuc
    Payne, Julia Y.
    Ayers, Gina
    Rothberg, Michael B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (03) : 377 - 383
  • [23] Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes
    Limonte, Christine P.
    Hall, Yoshio N.
    Trikudanathan, Subbulaxmi
    Tuttle, Katherine R.
    Hirsch, Irl B.
    de Boer, Ian H.
    Zelnick, Leila R.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (06)
  • [24] Prevalence of SGLT2i and GLP1RA Use among US Adults with Type 2 Diabetes
    Limonte, Christine
    Hall, Yoshio
    Trikudanathan, Subbulaxmi
    Tuttle, Katherine R.
    Hirsch, Irl B.
    De Boer, Ian
    Zelnick, Leila
    DIABETES, 2022, 71
  • [25] Using CVD risk scores to select between GLP-1RA or SGLT2i therapy in type 2 diabetes: modelling the combined effects on both major atherosclerotic and heart failure events
    Sacre, J. W.
    Magliano, D. J.
    Shaw, J. E.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S418 - S419
  • [26] Cardiovascular outcome with SGLT2i and GLP1RA
    Lim, Soo
    Sohn, Minji
    Nauck, Michael A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 129 : 133 - 136
  • [27] Extraglycemic Effects of SGLT2i/GLP1-ra: A Topic Update
    Alam, Uazman
    CLINICAL THERAPEUTICS, 2024, 46 (11) : 826 - 827
  • [28] Patient, provider and formulary characteristics associated with initiation of a SGLT2i or GLP-1RA among medicare beneficiaries with type 2 diabetes: A retrospective cohort study
    Luo, Jing
    Hernandez, Inmaculada
    Gabriel, Joseph
    Gellad, Walid
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 307 - 308
  • [29] Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus
    Jensen, Simon Kok
    Heide-Jorgensen, Uffe
    Andersen, Ina Trolle
    Thomsen, Reimar
    Christiansen, Christian Fynbo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I197 - I198
  • [30] Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus
    Jensen, Simon Kok
    Heide-Jorgensen, Uffe
    Andersen, Ina Trolle
    Thomsen, Reimar
    Christiansen, Christian Fynbo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
12345